Breast cancer screening is recommended for women aged 40 years and above. Over 70% of women reported receiving mammograms in the last two years between 2001 and 2020. Despite widespread screening, the impact on incidence trends of advanced breast cancer (aBC) in real-world settings in the last...
In 2024, the global breast cancer therapeutics market continues to grow rapidly, building on its valuation of $34 billion in 2023 and projected to reach $66 billion by 2032, with a steady CAGR of 6.8%. This growth is fueled by an increasing global incidence of breast cancer, coupled with ...
which has the highest incidence rate worldwide. This conference was established to fulfill the need for an academic event representing Korea and Asia. As one of the largest breast cancer conferences in Asia, GBCC aims to lead the region and boasts strong international networks. ...
它收集并分析癌症发病率、患病率、存活率和国内不同地理区域和人口的治疗模式的数据。 Breast cancer SEER NCI (Surveillance, Epidemiology, and End Results National Cancer Institute) is a program run by the National Cancer Institute in the United States. It collects and analyzes data on cancer incidence...
We describe temporal trends in breast cancer incidence by molecular subtypes in Scotland because public health prevention programmes, diagnostic and therapeutic services are shaped by differences in tumour biology. Population-based cancer registry data o
Therefore, we examined the trends of BC incidence and mortality during 1990–2014 and projected them to 2024 in Wuhan, Central China. Patients and methods: The incidence and mortality data of BC were extracted from the Wuhan Cancer Registry. The average annual percentage changes (AAPCs) of the...
Breast cancer is a leading cause of mortality and the most prevalent form of malignant tumor among women worldwide. Breast cancer cells exhibit an elevated
Breast cancer incidence has been on the rise significantly in the Asian population, occurring at an earlier age and a later stage. The potential predictive value of molecular subtypes, biomarkers, and genetic variations has not been deeply explored in the Asian population. This study evaluated the...
After the success of Breast pathology 2024 in Toronto we are inviting participants across the globe to attend 22nd International Conference on Breast Pathology and Cancer Diagnosis (Breast Pathology 2025) during June 19-20, 2025 in London, UK. The main theme of the conference is ‘Modern Innovati...
Breast cancer (BC) is one of the major public health challenges worldwide. Studies that address the new evidence on trends of BC are of great importance for preventing and controlling the occurrence and development of diseases and improving health. The a